Late-stage human trials showed that AstraZeneca's antibody drug reduced the risk of developing symptomatic COVID-19 by 77 percent.
More than three-quarters of the participants had suppressed immune systems and other conditions that made them more susceptible to severe disease.
The drugs are laboratory-made versions of virus-blocking antibodies that help fight off infections. The treatments help the patient by supplying concentrated doses of one or two antibodies. U.S. demand for the treatments soared over the summer, particularly in states like Florida, Louisiana and Texas, where unvaccinated patients threatened to overwhelm hospitals.
The main antibody treatments being used in the U.S. are from Regeneron and Eli Lilly & Co. The U.S. government has purchased bulk quantities of both drugs and oversees their distribution to the states.Read more
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
AstraZeneca seeks U.S. authorisation of drug to prevent COVID-19AstraZeneca has requested emergency use authorisation from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because of a weakened immune system.
Baca lebih lajut »
India's Divi's Labs hits record high on Merck's positive trial data for COVID-19 drugShares of India's Divi's Laboratories Ltd , which makes the main ingredient of Merck & Co's experimental antiviral pill, soared 10% on Monday, after the pharmaceutical giant reported positive clinical trial results for the drug.
Baca lebih lajut »
Why women are less likely than men to die from covid-19For the same reasons that women live longer: less booze and bravado, and different biology | Graphic detail
Baca lebih lajut »
Robots Take Over Italy’s Vineyards as Wineries Struggle With Covid-19 Worker ShortagesItalian winemakers have increasingly relied on migrant workers for the autumn harvest, but Covid-19 travel restrictions and soaring wage costs are pushing many to turn to machines.
Baca lebih lajut »
Alaska Hospitals Increasingly Ration Care as COVID-19 Infections SoarAlaska has activated emergency crisis protocols at 20 health care facilities.
Baca lebih lajut »
Amid COVID-19 booster data dilemma, EU nations' plans divergeA patchwork of campaigns for an extra COVID-19 shot are being rolled out across the European Union even before the region's drug watchdog rules on whether they are safe and effective.
Baca lebih lajut »